戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ist investigations (ie, computer tomography, cardiopulmonary exercise testing).
2  fraction <45%, stable conditions) underwent cardiopulmonary exercise test.
3 ardiography, pulmonary function tests, and a cardiopulmonary exercise test.
4 erformed during a maximal effort incremental cardiopulmonary exercise test.
5  undergone a Fontan procedure and subsequent cardiopulmonary exercise test.
6 ther medical risk factors, completed maximal cardiopulmonary exercise tests.
7 dimensional and Doppler echocardiography and cardiopulmonary exercise tests.
8 enetics Family Study at rest who underwent 2 cardiopulmonary exercise tests.
9 ntrol subjects were studied with incremental cardiopulmonary exercise testing.
10 cular measurements, 6-min walking tests, and cardiopulmonary exercise testing.
11 aired systolic function who are referred for cardiopulmonary exercise testing.
12 ssist device implantation) for 2 years after cardiopulmonary exercise testing.
13 chocardiograms with partial LVAD support and cardiopulmonary exercise testing.
14         The VE/VCO2 slope was determined via cardiopulmonary exercise testing.
15 0.03) were associated with maximal output on cardiopulmonary exercise testing.
16 LBBB) were studied with echocardiography and cardiopulmonary exercise testing.
17 New York Heart Association (NYHA) class, and cardiopulmonary exercise testing.
18 lly unrecognized HFpEF uncovered on invasive cardiopulmonary exercise testing.
19 hocardiographic criteria to undergo invasive cardiopulmonary exercise testing.
20 se electrocardiograms, echocardiography, and cardiopulmonary exercise testing.
21 th the gold standard peak oxygen uptake from cardiopulmonary exercise testing.
22 Heart Study) participants who also underwent cardiopulmonary exercise testing.
23 ulmonary hypertension qualified for invasive cardiopulmonary exercise testing.
24 nnaire Overall Summary Score (KCCQ-OSS), and cardiopulmonary exercise testing.
25  24 in the peak oxygen uptake as assessed by cardiopulmonary exercise testing.
26 tive phosphorylation, followed by whole-body cardiopulmonary exercise testing.
27 pulmonary disease (COPD), at rest and during cardiopulmonary exercise testing.
28 s with HF who underwent clinically indicated cardiopulmonary exercise testing.
29             P = 0.005) but no relations with cardiopulmonary exercise testing.
30 logy of Fallot (n=10) underwent MR-augmented cardiopulmonary exercise testing.
31 ) with hypertrophic cardiomyopathy underwent cardiopulmonary exercise testing.
32 ments, including stress echocardiography and cardiopulmonary exercise testing.
33 %) underwent maximum upright cycle ergometry cardiopulmonary exercise testing.
34 ratively and at 3 months postoperatively and cardiopulmonary exercise testing 3 months postoperativel
35 ion fraction, peak oxygen consumption in the cardiopulmonary exercise test, 6-min walk test, and qual
36 te of oxygen consumption at peak exercise on cardiopulmonary exercise testing, 6-minute walk distance
37 All participants underwent echocardiography, cardiopulmonary exercise testing, 6-minute walking test,
38 ise intolerance in 134 patients referred for cardiopulmonary exercise testing: 79 with HFpEF and 55 c
39 placebo on peak oxygen uptake as measured by cardiopulmonary exercise testing after 20 weeks of treat
40 ents with heart failure (HF), during maximal cardiopulmonary exercise test, anaerobic threshold (AT)
41                                              Cardiopulmonary exercise test and 6-minute walking test
42                     All patients underwent a cardiopulmonary exercise test and a phosphorus magnetic
43 ients with VSD aged 12 to 60 years underwent cardiopulmonary exercise test and echocardiography 1 day
44                 Between 2001 and 2009, using cardiopulmonary exercise test and echocardiography, we s
45 rves; secondary functional outcomes included cardiopulmonary exercise testing and arterial compliance
46                       All subjects underwent cardiopulmonary exercise testing and cardiac magnetic re
47                           Patients underwent cardiopulmonary exercise testing and echocardiography to
48 ogether with conventional methods, including cardiopulmonary exercise testing and echocardiography.
49 patients with heart failure underwent serial cardiopulmonary exercise testing and evaluation of exert
50 entified peripherally limited patients using cardiopulmonary exercise testing and measured skeletal m
51                                              Cardiopulmonary exercise testing and metabolite profilin
52 aximal oxygen uptake [VO(2)max]) measured by cardiopulmonary exercise testing and underwent 20 weeks
53  years, 27 females) completed seated upright cardiopulmonary exercise testing and were defined as hav
54  100 controls underwent lung function tests, cardiopulmonary exercise testing, and assessment of rest
55 underwent baseline Doppler echocardiography, cardiopulmonary exercise testing, and cardiac MRI.
56 rwent electrocardiography, echocardiography, cardiopulmonary exercise testing, and cardiovascular mag
57 ent clinical evaluation, pulmonary function, cardiopulmonary exercise testing, and chest computed tom
58            On visit 1 participants underwent cardiopulmonary exercise testing, and during subsequent
59 kers from clinical data, ECG, laboratory and cardiopulmonary exercise testing, and echocardiography.
60 ement electrocardiography, echocardiography, cardiopulmonary exercise testing, and genetic testing in
61 hort study using multimodal cardiac imaging, cardiopulmonary exercise testing, and Holter monitoring.
62 ters, including pulmonary function tests and cardiopulmonary exercise testing, and implemented multiv
63                            Echocardiography, cardiopulmonary exercise testing, and laboratory evaluat
64 unction testing, respiratory muscle testing, cardiopulmonary exercise testing, and muscle biopsy.
65     Maximum oxygen uptake was assessed using cardiopulmonary exercise testing, and results were expre
66 iratory muscle strength, six-minute walk and cardiopulmonary exercise tests, and were followed over 4
67                               Biomarkers and cardiopulmonary exercise testing are well validated in t
68 n fraction </=35%) underwent symptom-limited cardiopulmonary exercise testing as part of routine mana
69 -five consecutive patients with CF completed cardiopulmonary exercise testing as part of their pretra
70 dults with Fontan palliation who underwent a cardiopulmonary exercise test at Mayo Clinic were strati
71         Overall 243 HTx recipients performed cardiopulmonary exercise testing at 1 year after HTx.
72 er kilogram of body weight per minute during cardiopulmonary exercise testing at 6 months.
73 heart disease (age, 33+/-13 years) underwent cardiopulmonary exercise testing at a single center over
74 e was peak oxygen consumption, measured with cardiopulmonary exercise testing at baseline and 8 and 2
75             In SEQUOIA-HCM participants with cardiopulmonary exercise testing at baseline and week 24
76  change in the total workload as assessed by cardiopulmonary exercise testing at week 24.
77 ocardiography, pulmonary function tests, and cardiopulmonary exercise tests at follow-up, starting 3
78 f age during incremental cycle and treadmill cardiopulmonary exercise tests at three test sites, corr
79                           Patients underwent cardiopulmonary exercise testing before and after treatm
80 thout PH who performed a submaximal invasive cardiopulmonary exercise test between January 2013 and J
81  and maximal exercise capacity (peak VO2) on cardiopulmonary exercise testing, both measured at 12 mo
82 hold, a parameter that can be defined during cardiopulmonary exercise testing, but rise rapidly at hi
83 ve (AHRR; chronotropic incompetence <80%) on cardiopulmonary exercise testing by HIV serostatus and c
84                                 Conventional cardiopulmonary exercise testing can objectively measure
85                                        Using cardiopulmonary exercise testing, cardiovascular reserve
86 ncluded AF burden, peak oxygen uptake during cardiopulmonary exercise testing, changes in metabolic p
87                                              Cardiopulmonary exercise test combined with simultaneous
88 lation, underwent semisupine cycle-ergometry cardiopulmonary exercise testing combined with exercise
89                             Laboratory-based cardiopulmonary exercise testing coupled with serial phl
90 p of 34 patients underwent a symptom-limited cardiopulmonary exercise test (CPET) to assess maximal e
91 we aimed to analyse the changes induced by a cardiopulmonary exercise test (CPET) up to volitional ex
92                                            A cardiopulmonary exercise test (CPET) with expired gas an
93                                              Cardiopulmonary exercise testing (CPET) and N-terminal p
94                               Maximum effort cardiopulmonary exercise testing (CPET) and objective PA
95 ise capacity with the aid of a comprehensive cardiopulmonary exercise testing (CPET) and real-time ca
96                      The prognostic value of cardiopulmonary exercise testing (CPET) for survival in
97                                              Cardiopulmonary exercise testing (CPET) has an establish
98 gy and gas exchange analysis measured during cardiopulmonary exercise testing (CPET) has been associa
99        Unlike adult patients, the utility of cardiopulmonary exercise testing (CPET) in children as a
100 nes, and meta-analyses concerning the use of cardiopulmonary exercise testing (CPET) in preoperative
101                                              Cardiopulmonary exercise testing (CPET) is a valuable me
102                                              Cardiopulmonary exercise testing (CPET) is the criterion
103 bioimpedance and symptom-limited incremental cardiopulmonary exercise testing (CPET) on a cycle ergom
104 ation exists regarding the safety of maximal cardiopulmonary exercise testing (CPET) or the mechanism
105 e health-related quality of life (HRQOL) and cardiopulmonary exercise testing (CPET) performance of i
106    Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET) provides a thoro
107                                      Because cardiopulmonary exercise testing (CPET) provides informa
108  = 0.21) and isobaric hypoxic ( FiO2 = 0.12) cardiopulmonary exercise testing (CPET) to determine nor
109                                              Cardiopulmonary exercise testing (CPET) was prospectivel
110                                              Cardiopulmonary exercise testing (CPET) was used to obje
111 he exercise limitation in patients with PPH, cardiopulmonary exercise testing (CPET) with gas exchang
112                                 We conducted cardiopulmonary exercise testing (CPET), cardiac magneti
113 on between muscle thickness measurements and cardiopulmonary exercise testing (CPET), performed withi
114 ment on functional capacity as determined by cardiopulmonary exercise testing (CPET).
115                Interpretation of incremental cardiopulmonary exercise tests (CPET) might be enhanced
116                                              Cardiopulmonary exercise test (CPX) responses are strong
117                 In the past several decades, cardiopulmonary exercise testing (CPX) has seen an expon
118                                              Cardiopulmonary exercise testing (CPX) with measurement
119          Clinical, electrocardiographic, and cardiopulmonary exercise test data from 332 male profess
120                                     Baseline cardiopulmonary exercise testing data from the ARISE-HF
121                                      Whether cardiopulmonary exercise testing data predict survival h
122 ysis of the right ventricle, during invasive cardiopulmonary exercise testing, demonstrates that that
123 years, 78 +/- 11 kg), who completed invasive cardiopulmonary exercise testing during upright ergometr
124              Participants underwent baseline cardiopulmonary exercise testing, echocardiogram, biomar
125 atched for age, height, and weight underwent cardiopulmonary exercise testing, echocardiography inclu
126 ontan palliation (n = 29) underwent invasive cardiopulmonary exercise testing, echocardiography, and
127 ization, including serum biomarker analysis, cardiopulmonary exercise testing, echocardiography, and
128                   Subjects were studied with cardiopulmonary exercise testing, echocardiography, and
129 entary persons with seropositive RA, maximal cardiopulmonary exercise tests, fasting blood, and vastu
130 diac magnetic resonance imaging and invasive cardiopulmonary exercise testing following treatment (~1
131 d preserved exercise tolerance, the value of cardiopulmonary exercise testing for risk stratification
132     Consecutive subjects undergoing invasive cardiopulmonary exercise testing for unexplained dyspnoe
133 ak VO2>80% predicted) who underwent invasive cardiopulmonary exercise testing for unexplained exertio
134  data at rest and during maximal incremental cardiopulmonary exercise testing from 87 consecutive hea
135 Hispanic patients also displayed compromised cardiopulmonary exercise testing functional capacity.
136                                              Cardiopulmonary exercise test, functional class, blood s
137     In total, 24 participants (60% among the cardiopulmonary exercise testing group, 31% among the to
138 re classified according to peak VO(2) during cardiopulmonary exercise testing (&gt;14, 10-14, and <10 mL
139 th preserved ejection fraction identified by cardiopulmonary exercise testing have impairments in oxy
140 chocardiography at rest and immediately post-cardiopulmonary exercise test in 207 patients (63 +/- 8
141 uated the effects of sotatercept by invasive cardiopulmonary exercise testing in participants with pu
142 eft shunting can be detected by noninvasive, cardiopulmonary exercise testing in patients with PPH.
143                               The results of cardiopulmonary exercise testing in patients with struct
144     This article reviews the applications of cardiopulmonary exercise testing in prognosis among pati
145  improved exercise, we performed progressive cardiopulmonary exercise testing, including rest and pea
146                                              Cardiopulmonary exercise testing indices peak oxygen con
147                              Questionnaires, cardiopulmonary exercise testing, inflammatory markers,
148 clinical, laboratory, echocardiographic, and cardiopulmonary exercise test investigations at study en
149                  We have demonstrated that a cardiopulmonary exercise test is feasible in ambulatory
150 risk stratification imperative, but although cardiopulmonary exercise test is well established as a p
151                                 MR-augmented cardiopulmonary exercise testing is feasible in both hea
152                                              Cardiopulmonary exercise testing is feasible in children
153                                              Cardiopulmonary exercise testing is often used to evalua
154 bstruction; and in a subset of patients with cardiopulmonary exercise testing, ischemia burden was as
155                  These findings suggest that cardiopulmonary exercise testing may be a useful tool to
156                                      Routine cardiopulmonary exercise testing may be a useful tool to
157 or II, 6-min walk distance >/= 380 to 440 m, cardiopulmonary exercise test-measured peak oxygen consu
158                                              Cardiopulmonary exercise testing measures oxygen uptake
159                       Pre- and post-training cardiopulmonary exercise tests, MRI, and echocardiograph
160  underwent an echocardiographic (n = 73) and cardiopulmonary exercise test (n = 37) within 30 days we
161 consisting of ECG, Holter, echocardiography, cardiopulmonary exercise testing, N-terminal pro-brain n
162                         Retrospectively, the cardiopulmonary exercise tests of 71 PPH patients were s
163 ute walk distance, nor peak oxygen uptake at cardiopulmonary exercise testing on cardiopulmonary bicy
164 icipants were recruited and each underwent 4 cardiopulmonary exercise tests: one incremental and thre
165 k oxygen uptake < 85% predicted from maximal cardiopulmonary exercise testing; organ functions were a
166 nd electrocardiogram variables), functional (cardiopulmonary exercise test parameters), sociodemograp
167                     The relationship between cardiopulmonary exercise testing parameters and pregnanc
168                                              Cardiopulmonary exercise testing parameters are powerful
169   Although circulatory power and traditional cardiopulmonary exercise testing parameters can be used
170 e provide 5-year survival prospects based on cardiopulmonary exercise testing parameters in this grow
171         We hypothesized that combinations of cardiopulmonary exercise testing parameters may provide
172 logy, socioeconomic status, quality of life, cardiopulmonary exercise testing parameters, and biomark
173 ients with HFpEF (8 men, 12 women) underwent cardiopulmonary exercise testing (peak Vo(2)) and static
174  study was to assess for association between cardiopulmonary exercise test performance at 1 year afte
175                         Peak symptom-limited cardiopulmonary exercise tests performed in 57 clinicall
176 riuretic peptide, peak oxygen consumption by cardiopulmonary exercise testing (pkVO2), New York Heart
177 e production), and heart rate reserve during cardiopulmonary exercise testing predicted risk of early
178                                 Preoperative cardiopulmonary exercise testing predicts surgical outco
179 (2)T(12.5%) support its regular inclusion in cardiopulmonary exercise testing protocols evaluating ca
180                                              Cardiopulmonary exercise testing provides prognostic inf
181                                              Cardiopulmonary exercise testing provides strong prognos
182                    On multivariate analysis, cardiopulmonary exercise tests, pulmonary capillary wedg
183                                              Cardiopulmonary exercise testing rather than symptoms sh
184  at inclusion included region of enrollment, cardiopulmonary exercise test results, and use of sodium
185 rformance on a low-technology exercise test, cardiopulmonary exercise testing should be considered.
186 ing of Exacerbations in Heart Failure) Apple cardiopulmonary exercise testing study aims to investiga
187  then had pre-randomisation assessments with cardiopulmonary exercise testing, symptom questionnaires
188                                              Cardiopulmonary exercise test time increased by 0.48 min
189 surgical patients, heart rate recovery after cardiopulmonary exercise testing, time/frequency measure
190                                              Cardiopulmonary exercise testing, tissue Doppler echocar
191 nters, participants also undergo an invasive cardiopulmonary exercise test to assess changes in hemod
192  developed magnetic resonance (MR)-augmented cardiopulmonary exercise testing to achieve this goal an
193                       All subjects underwent cardiopulmonary exercise testing to analyze aerobic para
194 e patients (10 HFpEF and 11 HFrEF) underwent cardiopulmonary exercise testing to assess VO(2) kinetic
195 ty patients with HFrEF and obesity underwent cardiopulmonary exercise testing to collect measures of
196 ixty-one HCC patients underwent preoperative cardiopulmonary exercise testing to determine their anae
197 g listed for liver transplantation underwent cardiopulmonary exercise testing to determine ventilator
198 ejection fraction </=40%) patients underwent cardiopulmonary exercise testing to evaluate aerobic per
199                  The patients also underwent cardiopulmonary exercise testing to objectify functional
200 ion and at 12 weeks after discharge included cardiopulmonary exercise testing to quantify peak oxygen
201 4 months), and at 12 months, comprising: (1) cardiopulmonary exercise testing to quantify VO(2)peak a
202                                An integrated cardiopulmonary exercise test using a CO(2) rebreathing
203                                              Cardiopulmonary exercise testing variables included peak
204                                           On cardiopulmonary exercise testing, ventilatory response t
205            Exercise duration on the baseline cardiopulmonary exercise test was the most important pre
206          Heart rate recovery after a maximal cardiopulmonary exercise test was used as a surrogate fo
207                                 Preoperative cardiopulmonary exercise testing was included.
208                            Peak VO(2) during cardiopulmonary exercise testing was not different betwe
209                                              Cardiopulmonary exercise testing was performed in 335 co
210                                              Cardiopulmonary exercise testing was performed in 500 pa
211                                              Cardiopulmonary exercise testing was performed on 232 co
212  between increasing dyspnea and Vt%IC during cardiopulmonary exercise testing was similar.
213 ea and preserved LVEF who underwent invasive cardiopulmonary exercise testing, we find that 70 of 890
214                               Using invasive cardiopulmonary exercise testing, we hypothesized that e
215 g blood samples collected at the time of the cardiopulmonary exercise test were used to assay obesity
216 inute walk distance or peak oxygen uptake at cardiopulmonary exercise testing were inversely related
217 1), none of the other endpoints derived from cardiopulmonary exercise testing were met.
218                                      MRI and cardiopulmonary exercise testing were performed before a
219                                Parameters of cardiopulmonary exercise testing were recently identifie
220 c magnetic resonance imaging and noninvasive cardiopulmonary exercise testing were recruited from the
221 is of HFNEF and proven cardiac limitation by cardiopulmonary exercise testing were studied by standar
222                                              Cardiopulmonary exercise tests were conducted before and
223 g (CMR), echocardiogram, and cycle ergometry cardiopulmonary exercise tests were performed at 10 thro
224 al for patients with systolic heart failure, cardiopulmonary exercise tests were performed at baselin
225                          Maximum incremental cardiopulmonary exercise tests were performed.
226        The results of pulmonary-function and cardiopulmonary-exercise testing were generally within n
227           Potential predictors, derived from cardiopulmonary exercise testing, were compared with oth
228 eater impairment in exercise capacity during cardiopulmonary exercise testing, whereas Hispanic patie
229  dedicated to quality of life questionnaire, cardiopulmonary exercise testing, whereas measurements o
230 ea who underwent echocardiogram and invasive cardiopulmonary exercise testing (which defined 4 hemody
231  (VE/Vco(2)) slope is an index determined by cardiopulmonary exercise testing, which incorporates per
232  healthy controls performed a maximal graded cardiopulmonary exercise test with continuous measuremen
233  dyspnea, who underwent clinically indicated cardiopulmonary exercise test with invasive hemodynamic
234                       The relationships from cardiopulmonary exercise testing with clinical and labor
235                                              Cardiopulmonary exercise testing with echocardiographic
236 h an aortic valve area <=1.5 cm(2) underwent cardiopulmonary exercise testing with echocardiography.
237 l cohort with dyspnea on exertion undergoing cardiopulmonary exercise testing with hemodynamic monito
238 nd preserved ejection fraction who underwent cardiopulmonary exercise testing with invasive hemodynam
239 on fraction >=50% referred for comprehensive cardiopulmonary exercise testing with invasive hemodynam
240 n=18), and control subjects (n=30) underwent cardiopulmonary exercise testing with invasive hemodynam
241             We performed maximum incremental cardiopulmonary exercise testing with invasive hemodynam
242                                 We performed cardiopulmonary exercise testing with invasive monitorin
243  shunt and patients with large PFO underwent cardiopulmonary exercise tests with contrast transcrania
244 otal of 406 consecutive clinically indicated cardiopulmonary exercise tests with radial and pulmonary
245 bjects performed supine-cycle maximal-effort cardiopulmonary exercise tests, with measurements of car
246 h congenital heart disease who had undergone cardiopulmonary exercise testing within 2 years of pregn
247                               Survival after cardiopulmonary exercise testing without HTx or ventricu
248 l volume % predicted (p=0.04), lower maximal cardiopulmonary exercise testing workload (p=0.002), gre

 
Page Top